Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IPHA
IPHA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IPHA News
Innate Pharma Reports Share and Voting Rights Data for 2025
Jan 07 2026
Businesswire
Innate Pharma Releases Share and Voting Rights Data as of December 18, 2025
Dec 22 2025
Businesswire
Innate Pharma Releases 2026 Financial Calendar
Dec 11 2025
Businesswire
Innate Pharma Releases 2026 Financial Calendar with Key Dates
Dec 11 2025
Newsfilter
Innate Pharma Releases Share and Voting Rights Data as of November 27, 2025
Nov 28 2025
Businesswire
Innate Pharma Releases Share and Voting Rights Data as of November 27, 2025
Nov 28 2025
Newsfilter
Rocket Lab Shares Surge Over 9%; Check Out 20 Stocks Making Moves in Premarket Trading
Nov 11 2025
Benzinga
Most Active Stocks in Pre-Market Trading on November 10, 2025: IFRX, GREE, IPHA, TSLL, SQQQ, NVDA, PFE, BBAI, OSCR, IONQ, HLN, THS
Nov 10 2025
NASDAQ.COM
Edwards Lifesciences Analyst Becomes Optimistic; Check Out the Top 4 Upgrades for Wednesday
Oct 29 2025
Benzinga
BTIG Affirms Buy Rating for Innate Pharma, Keeps $8 Price Target Intact
Oct 29 2025
Benzinga
This Progressive Analyst Has Shifted to a Bearish Stance; Check Out the Top 3 Downgrades for Thursday
Sep 18 2025
Benzinga
Will Alphabet Surge Over 14%? Check Out These 10 Leading Analyst Predictions for Thursday
Sep 18 2025
Benzinga
HC Wainwright & Co. Lowers Innate Pharma Rating to Neutral
Sep 18 2025
Benzinga
Innate Pharma Reports Reduced Net Loss for H1, Announces 30% Workforce Reduction, Shares Decline
Sep 17 2025
NASDAQ.COM
Innate Pharma Releases Business Update and Financial Results for First Half of 2025
Sep 17 2025
Newsfilter
Preview of Innate Pharma SA (IPHA) Q2 2025 Earnings Report: Key Insights to Anticipate
Sep 16 2025
Yahoo Finance
Show More News
